MGCD0103 N-(2-Aminophenyl)-4-([[4-(pyridin-3-yl)pyrimidin-2-yl]amino]methyl)benzamide;MGCD0103;Mocetinostat;MGCD0103(Mocetinostat);MG0103;Mocetinostat (MGCD0103,MG0103);Mocetinostat (MGCD0103);N-(2-Aminophenyl 726169-73-9
Mocetinostat (MGCD0103) 基本信息 |
中文名称: | Mocetinostat (MGCD0103) |
中文同义词: | N-(2-氨基苯基)-4-([[4-(吡啶-3-基)嘧啶-2-基]氨基]甲基)苯甲酰胺 |
英文名称: | Mocetinostat (MGCD0103) |
英文同义词: | N-(2-Aminophenyl)-4-([[4-(pyridin-3-yl)pyrimidin-2-yl]amino]methyl)benzamide;MGCD0103;Mocetinostat;MGCD0103(Mocetinostat);MG0103;Mocetinostat (MGCD0103,MG0103);Mocetinostat (MGCD0103);N-(2-Aminophenyl)-4-([[4-(pyridin-3-yl)pyrimidin-2-yl]amino]methyl)benzamide Mocetinostat (MGCD0103) |
CAS号: | 726169-73-9 |
分子式: | C23H20N6O |
分子量: | 396.452 |
EINECS号: | |
相关类别: | 信号转导通路激酶抑制剂;Inhibitor;API;小分子抑制剂;Inhibitors;小分子抑制剂,天然产物 |
Mol文件: | 726169-73-9.mol |
Mocetinostat (MGCD0103) 性质 |
Mocetinostat (MGCD0103) 用途与合成方法 |
用途 | Mocetinostat is a multi-targeted histone deacetylase inhibitor used in cancer therapy. Mocetinostat is undergoing clinical trials for the treatment of various cancers including follicular lymphoma, Ho dgkin鈥檚 lymphoma and acute myelogenous leukemia. |
About|Contact|Cas|Product Name|Molecular|Country|Encyclopedia
Message|New Cas|MSDS|Service|Advertisement|CAS DataBase|Article Data|Manufacturers | Chemical Catalog
©2008 LookChem.com,License: ICP
NO.:Zhejiang16009103
complaints:service@lookchem.com Desktop View